In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 428 for your search:
Drug:  fludarabine phosphate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 to 65
Sponsor: Other
Protocol IDs: MCC-14178, NCT00361140

2.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25137, NCT01283386

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 4 to 70
Sponsor: Other
Protocol IDs: CDR0000066968, RP 98-15, RPCI-RP-9815, NCI-V99-1527, NCT00003816

4.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 50
Sponsor: Other
Protocol IDs: CHIMERIC-HM01, WSU-10-02-99-M01-FB, NCT00004255

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 35 and under
Sponsor: Other
Protocol IDs: MT2000-18, 9504M09637, NCT00176878

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: Over 60
Sponsor: Other
Protocol IDs: 012000, NCT00382759

7.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

8.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: MYFLAI07, NCT00909168

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor:
Protocol IDs: EORTC-06942

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: LRF-CLL4, LRG-MRC-LEUK-CLL4, EU-99030, MRC-LEUK-CLL4, NCT00004218, EUDRACT-58585610, ISRCTN58585610

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LEUK-AML-HR, EU-20008, NCT00005863

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: BNLI-MCD/FMD, EU-20035, NCT00006250

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000068650, EORTC-06992-CLL-3, NCT00017108

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENTA-GL303, UCLA-0104008, NCT00024440

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9011, CAN-NCIC-CL1, E-C9011, SWOG-9108, CALGB-9011, CL1

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-20921

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1813.00, NCI-2009-01532, P01CA078902, P30CA015704, FHCRC-1813.00, 5666, NCT00075478

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CAM314, 2004-000149-39, NCT00086580

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 102-14, BO17072, NCT00090051

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor: Other
Protocol IDs: PRIMA, NCT00140582

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 17 and under
Sponsor: Other
Protocol IDs: TRIAL, TRIAL Relapsed AML 2001/01, NCT00186966

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000454560, GCLLSG-CLL-8, EU-20560, ML17102, GCLLSG-CLL-8/ML17/02, NCT00281918

24.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: Geriatric
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL9, EU-20561, AMGEN-GCLLSG-CLL9, EUDRACT-2005-003014-15, NCT00281892

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL1, EU-20548, GCLLSG-138, MEDAC-GCLLSG-CLL1, NCT00262782
1     
New Search